Zhang et al. found that high expression of TGFB1 in the cancer-associated fibroblasts (CAFs) of SCLC patients was correlated with effective inhibition of tumor growth, enhanced sensitivity to radiotherapy, and antitumor immunity [20]. Here, TGFB1 is linked to neoplasm.